“I shut down again. I went blank. One minute I was spinning, and the next minute my mind was dragging itself around in a circle, like an old, arthritic dog trying to lie down. And then I just turned ...

The study included approximately 400 adults with a history of bipolar I disorder who had a current episode of mania. Iloperidone was associated with significant improvement in adults with bipolar I ...

Results of a phase 3 study show that treatment with lumateperone (Caplyta) significantly improved depressive symptoms for patients with major depressive episodes associated with both bipolar I and ...

Iloperidone, a second-generation antipsychotic used to treat schizophrenia, appears to be safe and effective in the treatment of bipolar mania, new research suggested. Results of the phase 3 ...

SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the ...

(RTTNews) - LB Pharmaceuticals Inc. (LBRX), a clinical-stage biopharmaceutical company, announced the initiation of a Phase 2 trial of investigational drug LB-102 in bipolar depression, dubbed ...

Please provide your email address to receive an email when new articles are posted on . Alkermes announced positive topline results from its phase 3b study of Lybalvi in young adults with ...

GH Research announced positive Phase 2a trial results for GH001 in postpartum and bipolar II depression, with high remission rates. GH Research PLC announced significant progress in its clinical ...